2024 ICD-10-CM Diagnosis Code T47.6X1

Poisoning by antidiarrheal drugs, accidental (unintentional)

ICD-10-CM Code:
T47.6X1
ICD-10 Code for:
Poisoning by antidiarrheal drugs, accidental (unintentional)
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system
        (T47)

T47.6X1 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of poisoning by antidiarrheal drugs, accidental (unintentional). The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Poisoning by antidiarrheal drugs, accidental (unintentional)

Non-specific codes like T47.6X1 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for poisoning by antidiarrheal drugs, accidental (unintentional):

  • Use T47.6X1A for initial encounter - BILLABLE CODE

  • Use T47.6X1D for subsequent encounter - BILLABLE CODE

  • Use T47.6X1S for sequela - BILLABLE CODE

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Accidental bismuth compound overdose
  • Accidental bismuth compound poisoning
  • Accidental kaolin overdose
  • Accidental kaolin poisoning
  • Accidental loperamide overdose
  • Accidental loperamide poisoning
  • Accidental pectin poisoning
  • Antidiarrheal overdose
  • Bismuth compound overdose
  • Bismuth compound poisoning
  • Kaolin overdose
  • Loperamide overdose
  • Loperamide poisoning
  • Poisoning by kaolin
  • Poisoning by pectin

Clinical Information

  • 1,4-alpha-Glucan Branching Enzyme

    in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
  • Amylopectin

    a highly branched glucan in starch.
  • Glycogen Storage Disease Type IV

    an autosomal recessive metabolic disorder due to a deficiency in expression of glycogen branching enzyme 1 (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. clinical features are muscle hypotonia and cirrhosis. death from liver disease usually occurs before age 2.
  • Charcoal

    an amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. the activated form of charcoal is used in the treatment of poisoning. (grant & hackh's chemical dictionary, 5th ed)
  • Diphenoxylate

    a meperidine congener used as an antidiarrheal, usually in combination with atropine. at high doses, it acts like morphine. its unesterified metabolite difenoxin has similar properties and is used similarly. it has little or no analgesic activity.
  • Kaolin

    the most common mineral of a group of hydrated aluminum silicates, approximately h2al2si2o8-h2o. it is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (from merck index, 11th ed) the name is derived from kao-ling (chinese: "high ridge"), the original site. (from grant & hackh's chemical dictionary, 5th ed)
  • Partial Thromboplastin Time

    the time required for the appearance of fibrin strands following the mixing of plasma with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). it is a test of the intrinsic pathway (factors viii, ix, xi, and xii) and the common pathway (fibrinogen, prothrombin, factors v and x) of blood coagulation. it is used as a screening test and to monitor heparin therapy.
  • Bacillus coagulans

    a microaerophilic, lactic acid producing species of bacillus that occurs in fermented foods. it also produces anti-infective agents and is used as a probiotic.
  • Lacticaseibacillus casei

    a rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. l. casei is catalase positive.
  • Lacticaseibacillus paracasei

    a species of lacticaseibacillus that occurs in the gut microbiota of healthy humans as well as fermented dairy products and fermented vegetables. it is used as a probiotic.
  • Lacticaseibacillus rhamnosus

    a species of gram-positive, rod-shaped bacteria used in probiotics.
  • Lactobacillus

    a genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment pentoses. most members were previously assigned to the lactobacillus delbrueckii group. pathogenicity from this genus is rare.
  • Lactobacillus acidophilus

    a species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. this organism produces the fermented product, acidophilus milk.
  • Lactobacillus crispatus

    a species of lactobacillus that occurs in the human gastrointestinal tract and the vagina of healthy women. it produces lactic acid and hydrogen peroxide, and is used as a probiotic. it is also used for the treatment and prevention of bacterial vaginosis.
  • Lactobacillus delbrueckii

    a species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing lactic acid. it is important in the manufacture of fermented dairy products.
  • Lactobacillus gasseri

    a species of lactobacillus that occurs in the human oral mucosa; gastrointestinal tract; and vagina. it produces bacteriocins, can modulate the immune response, and is used as a probiotic.
  • Lactobacillus helveticus

    a species of gram-positive bacteria isolated from milk and cheese-starter cultures.
  • Lactobacillus johnsonii

    a species of lactobacillus that occurs in the human gastrointestinal tract and vagina. it produces bacteriocins and hydrogen peroxide and is used as a probiotic.
  • Lactobacillus leichmannii

    a species of gram-negative bacteria isolated from milk, cheese, and compressed yeast.
  • Lactobacillus pentosus

    a species of lactobacillus that occurs in fermented foods where its ability to produce lactic acid; anti-infective agents; and bacteriocins make it useful as a food preservation agent. it is also used as a probiotic.
  • Lactobacillus plantarum

    a species of rod-shaped, lactic acid bacteria used in probiotics and silage production.
  • Latilactobacillus sakei

    a species of lactobacillus that occurs in fermented meat and fish. it produces the bacteriocin sakacin p and is used for food preservation and as a probiotic.
  • Levilactobacillus brevis

    a species of gram-positive, rod-shaped lactic acid bacteria that is frequently used as starter culture in silage fermentation, sourdough, and lactic-acid-fermented types of beer and wine.
  • Ligilactobacillus salivarius

    a species of lactobacillus that occurs in the human gastrointestinal tract and oral mucosa. it produces bacteriocins and is used as a probiotic.
  • Limosilactobacillus fermentum

    a species of gram-positive, rod-shaped bacteria associated with dental caries.
  • Limosilactobacillus reuteri

    a species of gram-positive, rod-shaped lactic acid bacteria found naturally in the human intestinal flora and breast milk.
  • Loperamide

    one of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
  • Saccharomyces boulardii

    a species of saccharomyces that is used as a probiotic, such as in the treatment of diarrhea and pseudomembranous enterocolitis associated with clostridium infections.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Poisoning by antidiarrheal drugs NOS

Table of Drugs and Chemicals

The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Activated charcoal [See Also: Charcoal, medicinal]T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
AmylopectinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Antidiarrheal drug NECT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Antidiarrheal drug NEC
  »absorbent
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
AttapulgiteT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth saltsT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »aluminate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »anti-infectives
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »formic iodide
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »glycolylarsenate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »nonmedicinal (compounds) NEC
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »subcarbonate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »subsalicylate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »sulfarsphenamine
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Carbo medicinalisT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
CharcoalT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »activated [See Also: Charcoal, medicinal]
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »fumes (Carbon monoxide)
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »fumes (Carbon monoxide)
    »industrial
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »antidiarrheal
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »poison control
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »specified use other than for diarrhea
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »topical
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
DifenoxinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
DiphenoxylateT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
FetoxilateT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Intestinal motility control drugT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Intestinal motility control drug
  »biological
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
KaolinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Kaolin
  »light
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LactobacillusT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »acidophilus
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »acidophilus
    »compound
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »bifidus, lyophilized
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »bulgaricus
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »sporogenes
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lignin hemicelluloseT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LomotilT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LoperamideT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Miyari bacteriaT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
PectinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Saccharomyces boulardiiT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6

Patient Education


Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.